Element Science is an innovative San Francisco-based medical device and digital health company focused on developing solutions at the intersection of clinical-grade wearable devices, machine learning algorithms and lifesaving therapies to address the needs of high-risk cardiovascular patients, primarily as they transition from the hospital to home.
The company was founded in 2011 by Uday Kumar, MD, a cardiac electrophysiologist by training, and founder of iRhythm Technologies (NASD: IRTC), a leading digital healthcare company focused on cardiac rhythm diagnosis.
Element Science is developing a proprietary next-generation wearable digital platform that unites patient centric human factor engineering, sophisticated machine learning algorithm development principles, and rigorous electromechanical medical device development standards. The platform will address leading causes of death and hospitalization due to heart disease. The first product, an unobstructive, low-profile personal wearable defibrillator, aims to redefine the treatment for temporary periods of elevated Sudden Cardiac Death (SCD) risk.
On March 3, 2020, Element Science announced a $145.6 million Series C financing round to fund the completion of clinical studies and initial commercialization of its SCD wearable defibrillator as well as the development of a family of products built upon its proprietary platform to address related unmet clinical needs.
Element Science is funded by: Third Rock Ventures, Google Ventures, Deerfield Healthcare, Qiming Ventures Partners USA, Cormorant Asset Management, and Invus Opportunities.
Element Science, Inc.
200 Kansas Street, Suite 210
San Francisco, CA 94103
(415) 872 – 6500